Date: December 15-16 2021
Online Livestream
On December 15-16, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 5th Virtual Clinical Trials conference, the industry’s most trusted and long-lasting conference on clinical trials. The event is hosted by
Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events.
As clinical trials are switching to more decentralized and hybrid models, a collaborative platform for the exchange of information is vital to keep up with the rapid growth. At the 5th Virtual Clinical Trials Conference, hear from those on the front lines of these remote applications and discuss the future of clinical trials from leading pharma industry stalwarts. At this 2-day event, attendees can learn how to successfully conduct clinal trial operating procedures and protocol design and learn what major obstacles to avoid in data compliance.
The speaking faculty consists of an eminent panel of dignitaries and pharma industry professional experts who will offer all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, applying innovative technologies, and many other insightful strategies to ensure your next clinical trial is a success. Clinicians, trial managers, clinical data experts, vendors, pharma companies, and scientists should leverage the opportunity offered by the conference.
Important topics of discussion include:
- Implement robust trial design techniques and SOPs to improve your internal processes
- Improve patient enrollment, safety monitoring, and follow up outcomes
- Enhance approaches to flexible protocol design in DCTs
- Increase collaboration measures to ensure quality in your decentralized approach
- Understand new and exciting technologies that will increase efficiencies in your trials
Adapt your organization to the virtual change at this 2-day event which will commence in a virtual setting from 8:30 am on 15th December. Attendees will hear how clinical trials are conducted in the European Union (“EU”) and the major changes clinical trials are facing around the globe. Other topics that will be discussed include standardizing safety operating procedures, understanding ways to eliminate duplicate data entry, and how eConsent helps with studies at the site, sponsor, and CROs level to achieve success.
For more information, please visit
https://ibn.fm/72Oh9.
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.